在未经治疗的原发性膜性病中使用奥比努祖马布:一系列观察性病例
Jinling Hao1, Jing Wang2, Pan Zhou1
1Department of Nephrology, Taiyuan Hospital of Peking University First Hospital, Taiyuan, Shanxi, China.
Nephrology (Carlton, Vic.)
|June 3, 2024
概括
在Rituximab无效的情况下,Obinutuzumab对治疗原发性膜性病 (PMN) 有希望. 这项研究发现,奥比努图祖马布有效降低蛋白尿和改善白蛋白水平,具有良好的安全性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 初级膜性脏病 (PMN) 是一种脏疾病.
- 利图西马布是一种常见的治疗方法,但并不总是有效的.
- 奥比努图祖马布是一种较新的B细胞消耗剂.
研究的目的:
- 评估奥比努图祖马布作为PMN的初始治疗方法.
- 与现有疗法相比,评估其有效性和安全性.
主要方法:
- 用obinutuzumab治疗的PMN患者的观察病例系列.
- 使用24小时尿液总蛋白 (24小时UTP) 和血清白蛋白评估治疗反应.
- 通过脂酶A2受体 (PLA2R) 抗体监测免疫缓解.
主要成果:
- 在6个月内,24小时UTP显著减少和血清白蛋白增加.
- 在16.7%的患者中完全缓解,在66.6%的患者中部分缓解.
- 在6个月后100%的免疫缓解;观察到B细胞枯竭.
- 报告了轻度至中度的与治疗有关的不良事件,没有严重事件.
结论:
- 奥比努图祖马布是PMN的有前途的初始治疗方法.
- 它显示出良好的有效性和可管理的安全概况.
- 进一步的大规模研究是有必要的.
更多相关视频
11:47Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
2.2K
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
397
相关概念视频
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
